1.MDR1-siRNA reverses multidrug resistance in KBv200 cells
Journal of Medical Postgraduates 2004;0(02):-
Objective: To study the effect of siRNA on multidrug resistance1(MDR1) gene expression in KBv200 cells. Methods: MDR1-siRNA was synthesized and transfected into KBv200 cells.The MDR1 mRNA and P-gp were assayed by RT-PCR and flow cytometry.Cytotoxicity was determined by a tetrazolium-based chemosensitivity assay(MTT).Cellular accumulation of Dox was measured by fluorescence spectrophotometry. Results: MDR1-siRNA decreased MDR1 mRNA and P-gp expression(P
2.The clinical progress of antisense technology in the treatment of cancer
Journal of Medical Postgraduates 2003;0(12):-
According to the base complementation, the principle antisense technology is the sequence specific binding of complementary antisense nucleic acids or their chemical modification to the nucleic acids in cells, resulting in the suppression or prevention of gene translation. For the treatment of cancer, a lot of antisense drugs have been designed, which target the genes involved in the pathogenesis of cancer. And some of them have been in clinical trials. The author reviewed the progress of the clinical trials of these antisense drugs.
3.Midline carcinoma with rearrangement of nuclear protein in testis gene.
Chinese Journal of Pathology 2011;40(3):209-212
Carcinoma
;
drug therapy
;
genetics
;
metabolism
;
pathology
;
radiotherapy
;
Desmoplastic Small Round Cell Tumor
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Gene Rearrangement
;
Head and Neck Neoplasms
;
drug therapy
;
genetics
;
metabolism
;
radiotherapy
;
Humans
;
Keratin-20
;
metabolism
;
Keratin-7
;
metabolism
;
Lymphatic Metastasis
;
Male
;
Mediastinal Neoplasms
;
drug therapy
;
genetics
;
metabolism
;
radiotherapy
;
Melanoma
;
metabolism
;
pathology
;
Neuroectodermal Tumors, Primitive
;
metabolism
;
pathology
;
Nuclear Proteins
;
genetics
;
metabolism
;
Oncogene Proteins
;
genetics
;
metabolism
;
Oncogene Proteins, Fusion
;
genetics
;
metabolism
;
Rhabdomyosarcoma
;
metabolism
;
pathology
;
Thymus Neoplasms
;
drug therapy
;
genetics
;
metabolism
;
radiotherapy
4.Follow up Screening of Extraction Process of Volatile Oil in Supplemented Xanthium Powder by GC MS
Gang WEI ; Jinxian LIU ; Chunliang FANG ;
Chinese Traditional Patent Medicine 1992;0(02):-
Objective: To screen the extraction process of volatile oil in Supplemented Xanthium Powder.Methods: The main compositions of volatile oil contained by every herb in prescription were followed up by GC MS. Results: The extraction process of volatile oil in Supplemented Xanthium Powder was established, that is, Flos Magnoliae and Cortex Moutan Radicis were powdered, their volatile oils were extracted with Herba Menthae together by the steam distillation; then 13 fold first fraction of distillata and 3 fold redistillation liquid were collected respectively; the volatile oil of Rhizoma Liqustici Chuanxiong was extracted with alcohol. Inasmuch as Fructus Xanthii and Radix Angelicae Dahuricae contained less volatile oil, at the same time, to avoide that Fructus Xanthii produced toxicity by water extraction and coumarinic lactones of Radix Angelicae Dahuricae was destroyed their oils were considered unfit for extraction. Conclusion: GC MS is a useful way for follow up optimization of the extraction process of volatile oil in compound prescription of Chinese medicinal and worthy of popularization.
5.Effects of Zn~(2+) on cell cycle changes induced by multiglucosidum tripterygii
Zhen′Gang WANG ; Fang WANG ; Aihua LIU ;
Chinese Journal of Rheumatology 2001;0(04):-
Objective To explore the effect of Zn 2+ on human leukemia promyelocyte (HL 60)cycle changes induced by multiglucoside tripterygii (MT).Methods ① HL 60 phenotype and membrane protein Fas expression was detected.② HL 60 was cultured with MT observing the cell forms and cell cycle changes,DNA electrophoresis results and the effect of Zn 2+ on the cell cycle change.Results ① The HL 60 were CD4 +CD8 -CD19 -IFN ? +IL 8 -,and the Fas protein expression was poorer.② Following culture of HL 60 with MT,the apoptosis relative cell cycle change appeared in HL 60.This change mainly affected G 2/M and S stage cells,and presented dose time correlation.③ Zn + nearly all blooked the effect of MT induced HL 60 cell cycle change.Conclusion ① HL 60 has Th1 lymphocyte like characteristics,and the Fas protein expression is poorer.② Zn + affects the MT induced HL 60 cell cycle change.It suggests that Zn + might affect the therapeutic and side effects during clinical treatment of many autoimmune diseases with MT.
6.Assay of ?-asarone and ?-asarone in Rhizoma acori tatarinowii by HPLC
Xuehong KE ; Gang WEI ; Yonggi FANG ;
Chinese Traditional Patent Medicine 1992;0(10):-
Objective: To determine ? asarone and ? asarone in Rhizoma acori tatarinowii(RAT) . Methods: HPLC condition consists of ODS C 18 column(150mm?4.6mm, 5?m), methanol: water(6∶4) as mobile phase containing potassium dihydrogen phosphate 1.4g and sodium lauryl sulfate 1.2g per 1000mL, detective wavelength at 257nm, flow rate at 1.0mL?min -1 . Results: For RAT the mean recovery of 99.02%( RSD =1.03%) for ? asarone, 101.26%( RSD =3.57%) for ? asarone are obtained, respectively. Conclusion: The method is sensitive, rapid and accurate.
7.Study on the immune tolerance induced by immature dendritic cells in coordination islet xenotransplantation
Gang ZHAO ; Fang WANG ; Chunyou WANG
Chinese Journal of Organ Transplantation 2003;0(06):-
Objective To investigate the inducible effect of immature dendritic cells (DC) on immune tolerance in coordination islet xenotransplantation.Methods Mature and immature DC were cultured from BALB/c mice with 20 ?g/L GM-CSF and 500 ?g/L GM-CSF+ 200 ?g/L IL-4, respectively, then loaded with major histocompatibility complex (MHC) antigen of Wistar rat. Mature and immature DC were injected into the mice with diabetes. After a week, the islets of Wistar rat or SD rat were transplanted under the envelop of left renal of the diabetes mice. The survival time of grafts was monitored. The immune reactivity of T cell was evaluated by mixed lymphocyte culture. Results Grafts in BALB/c mice pretreated with mature DC rejected quickly, while the survival time of grafts was significantly prolonged in the mice pretreated with immature DC. However, whether pretreated with mature DC or immature DC, grafts from SD rat were rejected soon. The splenocytes of tolerant mice showed mild proliferation. Conclusion The recipient pretreated with immature DC will lead to the anergy of T lymphocyte, and prolong the survival time of xeno-islet.
8.Immune deficiency dendritic cell loading antigen induce tolerance of islets grafts in xenotransplantation
Gang ZHAO ; Fang WANG ; Chunyou WANG
Chinese Journal of Immunology 2000;0(08):-
Objective:To investigate the effect of host derived immune deficient dendritic cell(DC) on immune tolerance in transplantation of xenoislet.Methods:Mature or immune deficient DC were cultured from BALB/c mice and loaded with MHC antigen of Wistar rat. The DC were injected into the diabetes mice through tail venous, then islets of Wistar or SD rats were implanted beneath the capsule of renal after one week. Survival time of grafts was monitored. Mixed lymphocyte culture and Th1/Th2 cytokine were performed.Results:Surviving time of Grafts in normal group was 8.2?1.1 d, and that of mature DC treated group was 6.1?1.1 d(P
9.Group Ⅱ and Ⅲ metabotropic glutamate receptors agonists reverse 1-methyl-4-phenylpyridinium -induced glutamate uptake inhibition
Fang WANG ; Honghong YAO ; Gang HU
Chinese Journal of Clinical Pharmacology and Therapeutics 2002;0(05):-
AIM: To study the effects of group Ⅱ and Ⅲ metabotropic glutamate receptors (mGluRs) agonists on 1-methyl-4-phenylpyridinium (MPP+) -induced glutamate uptake inhibition. METHODS: The glutamate uptake into astrocytes was measured by using radio-ligand binding assay method,and the viability of astrocytes was investigated by MTT method. RESULTS: It was shown that MPP+(150, 200 ?mol?L -1 ) inhibited glutamate uptake into astrocytes,but produced no effect on the viability of astrocytes,and the inhibition rates were 58.3 % and 70.1 %,respectively. Group Ⅱ mGluRs agonist (2'S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV) ( 0.1 ,1,10, 100 ?mol?L -1 ) and Group Ⅲ mGluRs agonist L(+)-2-amino-4-phosphonobutyric acid (L-AP4) (1,10, 100 ?mol?L -1 ) significantly reversed MPP+-induced glutamate uptake inhibition. CONCLUSION: MPP+ directly inhibits the function of glutamate transporters,and group Ⅱ and Ⅲ mGluRs agonists produce neuroprotective effects by enhancing the activity of glutamate transporters.
10.Group Ⅱ and Ⅲ metabotropic glutamate receptors agonists reverse 1-methyl-4-phenylpyridinium-induced glutamate uptake inhibition in C6 glioma cells
Fang WANG ; Honghong YAO ; Gang HU
Chinese Journal of Clinical Pharmacology and Therapeutics 2004;0(10):-
AIM: To study the effect of group Ⅱ and Ⅲ metabotropic glutamate receptors (mGluRs) agonists on 1-methyl-4-phenylpyridinium (MPP~+)-induced glutamate uptake inhibition in C6 glioma cells. METHODS: The glutamate uptake into astrocytes was measured by using radio-ligand binding assay method. RESULTS: It was shown that Group Ⅱ mGluRs agonist (2' S, 2' R, 3 ' R) -2- (2', 3 ' -dicarboxycyclopropyl) glycine (DCG-Ⅳ) (100 ?mol?L~(-1)) and Group Ⅲ mGluRs agonist L(+)-2-amino-4-phosphonobutyric acid (L-AP4) (100 ?mol?L~(-1)) significantly reversed MPP~+-induced glutamate uptake inhibition. Furthermore, the enhancement effects of DCG-Ⅳ and L-AP4 were blocked by their respective antagonists, (RS)-1 -Amino-5-phosphonoinan-1-carboxylic acid (APICA) and (RS)-?-methylserine-O-phosphate (MSOP). CONCLUSION: Group Ⅱ and Ⅲ mGluRs agonists produce neuroprotective effects by enhancing the activity of glutamate transporters.